Anavex Life Sciences to Participate in The Citizens Life Sciences Conference
12 Health Care Stocks Moving In Monday's After-Market Session
We're Not Worried About Anavex Life Sciences' (NASDAQ:AVXL) Cash Burn
Express News | Anavex Life Sciences Announces Appointment of DR. Audrey Gabelle, Md, Phd to the Scientific Advisory Board
Press Release: Anavex Life Sciences Announces Appointment of Dr. Audrey Gabelle, MD, PhD to the Scientific Advisory Board
Anavex Life Sciences Announces Presentation at 9th International Conference on Alzheimer's Disease and Related Disorders in the Middle East
Anavex Life Sciences Reports Prolonged Benefit Data Of Blarcamesine In Early Alzheimer's Over 3 Years
Anavex Life Sciences Price Target Maintained With a $46.00/Share by D. Boral Capital
Anavex Life Sciences Is Maintained at Buy by D. Boral Capital
Express News | Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results From Phase Iib/III Open-Label Extension Trial in Early Alzheimer’s Disease
Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results From Phase IIb/III Open-Label Extension Trial in Early Alzheimer's Disease
Anavex Life Sciences to Present at the 24th Annual Needham Virtual Healthcare Conference
Beat the Market the Zacks Way: Amgen, DRDGOLD, Anavex in Focus
JonesTrading Maintains Anavex Life Sciences(AVXL.US) With Buy Rating, Maintains Target Price $15
Analysts Offer Insights on Healthcare Companies: Anavex Life Sciences (AVXL) and Applied DNA Sciences (APDN)
Anavex Life Sciences Corp.'s (NASDAQ:AVXL) Shift From Loss To Profit
Anavex Life Sciences to Present at the 45th Annual TD Cowen Health Care Conference
Buy Rating for Anavex Life Sciences Due to Solid Financials and European Market Potential
Anavex Life Sciences Reports Higher Quarterly Loss Amid R&D Focus
Stocks Trim Losses After Hot Inflation, Bonds Remain Pressured, Tesla Rebounds: What's Driving Markets Wednesday?